Apogee Therapeutics Inc. (APGE) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Apogee Therapeutics Inc.

    NASDAQ: APGE · Real-Time Price · USD
    39.88
    0.27 (0.68%)
    At close: Oct 03, 2025, 3:59 PM
    39.88
    0.00%
    After-hours: Oct 03, 2025, 04:20 PM EDT

    Apogee Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
    Net Income
    		 -182.15M -83.98M -39.78M
    Depreciation & Amortization
    		 189K n/a n/a
    Stock-Based Compensation
    		 23.33M 6.1M 2.14M
    Other Working Capital
    		 -930K 4.49M 9.4M
    Other Non-Cash Items
    		 -10.55M -2.98M 11.4M
    Deferred Income Tax
    		 n/a n/a n/a
    Change in Working Capital
    		 -2M 6.11M 9.81M
    Operating Cash Flow
    		 -171.17M -74.76M -16.43M
    Capital Expenditures
    		 -1.15M -167K n/a
    Cash Acquisitions
    		 n/a n/a n/a
    Purchase of Investments
    		 -649.45M -303.74M n/a
    Sales Maturities Of Investments
    		 350.14M 30M n/a
    Other Investing Acitivies
    		 n/a n/a n/a
    Investing Cash Flow
    		 -300.46M -273.91M n/a
    Debt Repayment
    		 n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a
    Other Financial Acitivies
    		 1.63M n/a 183.62K
    Financial Cash Flow
    		 495.11M 315.39M 183.62K
    Net Cash Flow
    		 23.47M -33.28M -16.24M
    Free Cash Flow
    		 -172.33M -74.93M -16.43M

    Add to Watchlist